Related Experiment Video
Updated: Jun 13, 2026
08:48
Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models
Published on: June 30, 2023
Mitochondrial matters in Huntington disease
1Department of Medicine, The Johns Hopkins School of Medicine, Baltimore, MD, USA. gsack@jhmi.edu
Journal of Bioenergetics and Biomembranes
|May 13, 2010
Summary
Huntington Disease (HD) is an inherited neurological disorder caused by a CAG trinucleotide repeat expansion. This expansion leads to a mutant Huntingtin protein, impacting brain function and offering potential therapeutic targets.
Area of Science:
- Neurogenetics
- Molecular Biology
- Mitochondrial Biology
Background:
- Huntington Disease (HD) is a common inherited neuropathy with cognitive and behavioral symptoms, typically emerging in adulthood.
- It serves as a model for neurogenetic disorders stemming from trinucleotide repeat expansions.
- The disease is characterized by the expansion of the (CAG)(n) repeat in the huntingtin gene.
Purpose of the Study:
- To review the molecular basis of Huntington Disease.
- To explore the role of mitochondria in HD pathophysiology.
- To discuss potential therapeutic interventions targeting mitochondrial dysfunction.
Main Methods:
- Review of existing literature on Huntington Disease genetics and pathophysiology.
- Analysis of molecular mechanisms involving trinucleotide repeat expansion and mutant Huntingtin protein.
- Examination of evidence linking mitochondrial dysfunction and PGC-1 alpha to HD.
Main Results:
- HD is caused by an expansion of the CAG repeat in the huntingtin gene, leading to an extended polyglutamine tract in the mutant Huntingtin protein.
- Mitochondrial alterations, including impaired electron transport and increased brain lactate, are implicated in HD.
- Reduced PGC-1 alpha transcription contributes to altered gene regulation in affected individuals.
Conclusions:
- Mitochondrial dysfunction is a key factor in Huntington Disease pathogenesis.
- Understanding these mitochondrial derangements opens avenues for therapeutic strategies.
- Targeting mitochondrial pathways may offer novel treatment options for HD.
More Related Videos
Related Concept Videos
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
01:19Translocation of Proteins into the Mitochondria
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
01:37Mitochondria
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
01:48ATP Synthase: Mechanism
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:39Mitochondrial Precursor Proteins
Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70 chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial precursors...
Most of the mitochondrial precursors...